Document is current

Article History

Received: 12 June 2024

Accepted: 1 November 2024

First Online: 2 December 2024

Declarations

:

: The study was performed in accordance with the principles of the Declaration of Helsinki. Before commencing the study, approval was obtained from the local Ethics Committee (S-193/2022) and the collection of this patient data was registered in the Clinical Trials Register (DRKS00007837). All patients provided written informed consent to participate in this study prior to any study-related examinations.

: Not applicable.

: Timur M. Yildirim receives personal fees from Alcon and Hoya, and non-financial support from Johnson & Johnson, outside the submitted work. Victor A. Augustin reports grants from Kowa and Eyeyon. Ramin Khoramnia reports grants, personal fees, and non-financial support from Alcon, Johnson & Johnson, Hoya, Physiol, Rayner, personal fees, and non-financial support from Kowa, Ophtec, Oculentis/Teleon, Santen, and Acufocus, outside the submitted work. Gerd U. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson & Johnson and Alcon, grants, personal fees, and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, Ursapharm, grants, and personal fees from Biotech, Oculus, EyeYon grants from Acufocus, Anew, Contamac, Glaukos, Physiol, Rheacell, outside the submitted work. Grzegorz Łabuz, Hyeck-Soo Son, Nikola Henningsen, Leoni Britz and Lizaveta Chychko have nothing to disclose.